[go: up one dir, main page]

MD2375F1 - Method of portal gastropathy treatment in hepatic cirrhosis - Google Patents

Method of portal gastropathy treatment in hepatic cirrhosis Download PDF

Info

Publication number
MD2375F1
MD2375F1 MD20030192A MD20030192A MD2375F1 MD 2375 F1 MD2375 F1 MD 2375F1 MD 20030192 A MD20030192 A MD 20030192A MD 20030192 A MD20030192 A MD 20030192A MD 2375 F1 MD2375 F1 MD 2375F1
Authority
MD
Moldova
Prior art keywords
gastropathy
portal
treatment
hepatic cirrhosis
days
Prior art date
Application number
MD20030192A
Other languages
Romanian (ro)
Other versions
MD2375G2 (en
Inventor
Constantin Tibirna
Boris Pirgari
Gheorghe Anghelici
Ion Panici
Viorel Moraru
Veaceslav Tacu
Original Assignee
Constantin Tibirna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Constantin Tibirna filed Critical Constantin Tibirna
Priority to MDA20030192A priority Critical patent/MD2375G2/en
Publication of MD2375F1 publication Critical patent/MD2375F1/en
Publication of MD2375G2 publication Critical patent/MD2375G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to medicine, in particular to the surgical hepatology Summary of the method consists in the multiple endoscopic injection of the ozonized 0,9% NaCl solution in the concentration of 2000...4000 µg/L into the submicous layer of the affected zones in a quantity of 2...4 ml, which is carried out in 2...4 procedures at an interval of 2...3 days. Simultaneously, it is perorally administered ozonized vegetable oil, in the concentration of 8000...10000 µg/L in a quantity of 5...15 ml 3...4 times a day during 8...10 days Claims: 1
MDA20030192A 2003-07-29 2003-07-29 Method of portal gastropathy treatment in hepatic cirrhosis MD2375G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20030192A MD2375G2 (en) 2003-07-29 2003-07-29 Method of portal gastropathy treatment in hepatic cirrhosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20030192A MD2375G2 (en) 2003-07-29 2003-07-29 Method of portal gastropathy treatment in hepatic cirrhosis

Publications (2)

Publication Number Publication Date
MD2375F1 true MD2375F1 (en) 2004-02-29
MD2375G2 MD2375G2 (en) 2004-08-31

Family

ID=32065049

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20030192A MD2375G2 (en) 2003-07-29 2003-07-29 Method of portal gastropathy treatment in hepatic cirrhosis

Country Status (1)

Country Link
MD (1) MD2375G2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2551G2 (en) * 2003-12-03 2005-03-31 Андрей ПЫРГАРЬ Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses
MD2933G2 (en) * 2005-06-23 2006-08-31 Виктор ГИКАВЫЙ Method of treatment of the skin affections

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3477G2 (en) * 2007-03-21 2008-08-31 Николае БОДРУГ Method of treating the chronic viral hepatitis C
MD3444G2 (en) * 2007-05-17 2008-07-31 Борис ПЫРГАРЬ Method of treating the spontaneous bacterial peritonitis in the decompensated hepatic cirrhosis with resistant ascitic syndrome

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2551G2 (en) * 2003-12-03 2005-03-31 Андрей ПЫРГАРЬ Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses
MD2933G2 (en) * 2005-06-23 2006-08-31 Виктор ГИКАВЫЙ Method of treatment of the skin affections

Also Published As

Publication number Publication date
MD2375G2 (en) 2004-08-31

Similar Documents

Publication Publication Date Title
BR0316753A (en) Treatment method for sexual dysfunction
BRPI0509139A (en) composition, and method of stimulating an immune response in an individual, prophylactically treating a disease, ameliorating a sign or symptom associated with a disease, tumor targeting, tumor growth inhibition, and detection of a tumor
TW200503674A (en) Therapeutic agents
IL156827A (en) 2-mercapto-[1,3]thiazolo[5,4-b]pyridine derivatives and pharmaceutical compositions comprising them for treating cardiovascular diseases
EA200601846A1 (en) CONTAINING BENZOXASINS MEDICINAL COMBINATIONS FOR THE TREATMENT OF DISEASES OF RESPIRATORY TRACKS
NZ599292A (en) Vitamin d compositions and method of administration to a human being
BRPI0409359A (en) somatostatin-dopamine chimeric analogs
MXPA05012392A (en) Anxiety treatments with ziprasidone.
GB2431346B (en) A combination composition comprising paracetamol and ibuprofen
WO2007056264A3 (en) Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
NO20062739L (en) Controlled release of topirimate in liquid dosage form
MX2007004955A (en) Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally.
ATE460940T1 (en) IRON(III) COMPLEX COMPOUNDS FOR THE ORAL TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH CHRONIC INFLAMMATORY BOWEL DISEASE
MD2375F1 (en) Method of portal gastropathy treatment in hepatic cirrhosis
AR043117A1 (en) TREATMENT OF BACTERIAL DISEASES OF RESPIRATORY ORGANS
EA200800397A1 (en) TIZANIDINE COMPOSITIONS AND TREATMENT METHODS USING COMPOSITIONS
RU2003127718A (en) APPLICATION OF FLUMAZENIL IN THE PRODUCTION OF A MEDICINE FOR TREATING COCAIN DEPENDENCE
EA200900269A1 (en) DRUG COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
WO2006108681A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against bacteria
WO2007104933A8 (en) Chemical compounds
WO2005055933A3 (en) Treatment of psoriasis with rosiglitazone
MXPA05013975A (en) Treatment of amyloid- and epileptogenesis-associated diseases.
EA200700413A1 (en) ARYLAMINKETONES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE
MD2354F1 (en) Method of treatment of the hepatic encephalopathy
WO2007047893A3 (en) Use of dasatinib for the treatment of bone metastasis

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees